Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting.
Gotto
A M
AM
Department of Medicine, Baylor College of Medicine, Methodist Hospital, Houston, TX 77030, USA.
D003324:Coronary Artery Disease / Q000188:drug therapy / Q000378:metabolism; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism* / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D050356:Lipid Metabolism; D012307:Risk Factors
D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors